← Back to Search

Behavioural Intervention

Cognitive Behavioral Therapy for Benzodiazepine Abuse (CSTARS Trial)

N/A

Recruiting

Led By Gloria Yeh, MD

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 0 and immediately after 10 weeks of participation

Awards & highlights

CSTARS Trial Summary

This trial will test if a therapy can help seniors reduce their benzodiazepine use safely.

Who is the study for?

This trial is for older adults (65+) who have been prescribed benzodiazepines long-term by their primary care doctors at BIDMC Healthcare Associates Clinic. It's not suitable for those whose doctors opt out or patients with severe anxiety or depression.Check my eligibility

What is being tested?

The study tests a brief cognitive-behavioral therapy program designed to help participants reduce and stop using benzodiazepine medications safely under medical supervision.See study design

What are the potential side effects?

While the trial itself focuses on therapy, reducing benzodiazepines may lead to withdrawal symptoms such as sleep disturbances, increased anxiety, irritability, and mood swings.

CSTARS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 0 and immediately after 10 weeks of participation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 0 and immediately after 10 weeks of participation

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0 and immediately after 10 weeks of participation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability: Likert Scale responses

Acceptability: Open-ended qualitative interview

Feasibility: Intervention adherence

+1 more

Secondary outcome measures

Behavior: Attitudes

Behavior: Intentions

Behavior: Knowledge

+2 more

CSTARS Trial Design

1Treatment groups

Experimental Treatment

Group I: Benzodiazepine Medication Taper with Cognitive Behavioral TherapyExperimental Treatment1 Intervention

Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor

837 Previous Clinical Trials

13,010,252 Total Patients Enrolled

6 Trials studying Insomnia

3,955 Patients Enrolled for Insomnia

University of California, San FranciscoOTHER

2,507 Previous Clinical Trials

15,238,555 Total Patients Enrolled

8 Trials studying Insomnia

1,073 Patients Enrolled for Insomnia

University of PittsburghOTHER

1,723 Previous Clinical Trials

16,343,136 Total Patients Enrolled

8 Trials studying Insomnia

1,095 Patients Enrolled for Insomnia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What key objectives is this trial attempting to achieve?

"The principal purpose of this research trial, which will be tracked over a 10 week period, is to assess adherence with the intervention. Supplementary objectives include gauging participants' intentions towards avoiding benzodiazepines for sleep and anxiety on a 15-point scale; measuring attitudes around reducing benzo use through a 7 point Likert rating system; as well as testing knowledge about risks/benefits via 8 true or false questions."

Answered by AI

Are any slots available for enrolment in this clinical trial?

"Visiting clinicaltrials.gov will reveal that this trial is not currently seeking participants, as its last update was on 2nd November 2023. While recruitment has ceased for this particular study, there are 573 other trials actively recruiting patients right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing

Gloria Y. Yeh 2023. "Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06119308.